Transcript No Slide Title

The James Lind Alliance
Clinicians’ Perspective:
Opportunities and Challenges
John Scadding
JLA Annual Meeting, 3 December 2005
RSM, London
James Lind
Alliance
JLA Opportunities for Clinicians
James Lind
Alliance
1.
2.
3.
4.
5.
6.
Address issues of importance & relevance to patients.
Patients & clinicians set priorities for research, not
industry.
Quality patient participation, not just numbers in trials.
Minimise biases of individuals in research.
Better recruitment of patients to studies: understanding
of trial methods.
Identification of under-researched areas.
JLA Opportunities for Clinicians
James Lind
Alliance
7.
8.
Identification of systematic reviews needed.
Easier passage of research proposals through ethics
committees.
9. Attraction of non-commercial funding.
10. Ensure relevant trials are conducted: new vs best
existing treatment.
11. Greater involvement of NHS clinicians in therapeutic
research.
12. More research done as part of routine NHS healthcare.
JLA Challenges for Clinicians
James Lind
Alliance
1.
2.
3.
4.
5.
6.
Ability to work in collaboration with patients, other
clinicians, DUETs, & Cochrane review groups.
Ensure appropriate clinician groups & individuals contribute
to working partnerships.
Set aside personal agendas.
Methods for systematic acquisition of clinicians’ views and
experiences (as with patients, for DUETs).
Development of skills to reach consensus decisions.
Working to patient defined outcomes in research.
JLA Challenges for Clinicians
James Lind
Alliance
Listen to patients’ views on quality of life measures.
Listen to patients’ views on interventions to be measured in
research.
9. Engage in research within constraints of the new
consultant contract.
10. Work with NHS managers: importance of research in
routine care.
11. Influence metrics for incentives in patient focused research
in healthcare.
12. Work within framework of CRNs: “Best Research for Best
Health”.
7.
8.
James Lind
Alliance
www.lindalliance.org